Term
|
Definition
| non-Hodgkin's lymphoma; some leukemias |
|
|
Term
|
Definition
| some breast cancers and some gastric cancers |
|
|
Term
|
Definition
|
|
Term
| Denileukin diftitox (Ontak) |
|
Definition
| leukemias and lymphomas where cancerous WBCs kill CD25 |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| chronic myelogenous leukemia (CML) and other leukemias that are BCL-ABL + |
|
|
Term
|
Definition
| thought to activate immune system (T cells) but has some severe side effects |
|
|
Term
|
Definition
| Anti (alpha) viral responses; promotes T cells as well as acting directly on tumor cells to slow rate of proliferation |
|
|
Term
|
Definition
| TKI that stops proliferation and inhibits angiogenesis |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Brotezomib (velcade) and Carfilzomib (Kyprolis) |
|
Definition
|
|
